Internal Medicine, Gastroenterology · Sacramento, CA
NPI
1558457960
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2725 Capitol Ave, Suite 300
Sacramento, CA, 95816
Phone (916) 262-9370
Groups this clinician bills Medicare through
Medicare paid, 2024
$125K
1,337 services
Medicare patients, 2024
620
Average age 74
Drug cost, 2024
$1.1M
2,001 prescriptions
Company payments, 2025
$1,099
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abdul M Khaleq was code G0500 (moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito), 312 times for 309 patients. In total Abdul M Khaleq billed 1,337 services in 47 codes, and Medicare paid $125K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 312 | 309 | $3.97 | $1,239 |
| 45385 Colonoscopy - Lesion Removal | Facility | 191 | 190 | $201.93 | $39K |
| 45380 Lower GI Endoscopy - Other | Facility | 190 | 190 | $85.95 | $16K |
| 43239 Upper GI Endoscopy | Facility | 167 | 165 | $69.41 | $12K |
| 99214 Office E&M - Established | Office | 140 | 118 | $97.13 | $14K |
| 99204 Office E&M - New | Office | 71 | 71 | $124.63 | $8,849 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 31 | 31 | $181.71 | $5,633 |
| 99213 Office E&M - Established | Office | 22 | 22 | $56.12 | $1,235 |
| 45378 Lower GI Endoscopy - Other | Facility | 17 | 17 | $121.77 | $2,070 |
| 43249 Upper GI Endoscopy | Facility | 15 | 15 | $108.45 | $1,627 |
| 43235 Upper GI Endoscopy | Facility | 13 | 13 | $79.72 | $1,036 |
| 45388 Lower GI Endoscopy - Other | Facility | 12 | 12 | $219.58 | $2,635 |
| 74328 Digestive/Gastrointestinal | Facility | 11 | 11 | $18.78 | $207 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 11 | 11 | $185.03 | $2,035 |
| 43251 Upper GI Endoscopy | Facility | 11 | 11 | $117.08 | $1,288 |
By year: 2022 $123K for 1,375 services; 2023 $132K for 1,383 services; 2024 $125K for 1,337 services.
Medicare prescription drug claims, 2024
In 2024, the drug Abdul M Khaleq prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 479 prescriptions and refills. In total Abdul M Khaleq wrote 2,001 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 479 | 479 | 468 | $31K |
| Omeprazole Generic | 293 | 612 | 78 | $4,396 |
| Pantoprazole Sodium Generic | 140 | 245 | 42 | $1,565 |
| Mesalamine Generic | 111 | 193 | 24 | $56K |
| Famotidine Generic | 96 | 196 | 29 | $1,660 |
| Linzess Linaclotide | 82 | 106 | 22 | $55K |
| Sucralfate Generic | 65 | 71 | 19 | $6,310 |
| Mercaptopurine Generic | 45 | 83 | Under 11 | $5,102 |
| Creon Lipase/Protease/Amylase | 42 | 57 | 13 | $116K |
| Nortriptyline Hcl Generic | 37 | 59 | Under 11 | $385 |
| Dicyclomine Hcl Generic | 34 | 64 | 15 | $1,121 |
| Dexlansoprazole Dr Dexlansoprazole | 32 | 54 | Under 11 | $8,006 |
| Duloxetine Hcl Generic | 25 | 34 | Under 11 | $526 |
| Promethazine Hcl Generic | 24 | 24 | Under 11 | $167 |
| Esomeprazole Magnesium Generic | 19 | 27 | Under 11 | $1,795 |
Brand drugs: - claims; generic drugs: 1,568 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abdul M Khaleq $1,099 ($1,099 in general payments such as food, travel and fees) from 9 companies. The largest payer was Janssen Scientific Affairs, LLC with $327.
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC JNJ | 3 | $327 |
| Abbvie Inc. ABBV | 3 | $250 |
| Celltrion USA Inc. 068270.KS | 2 | $122 |
| Genzyme Corporation SNY | 1 | $107 |
| Janssen Biotech, Inc. JNJ | 9 | $94.93 |
| Ardelyx, Inc. ARDX | 4 | $91.46 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $66.73 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $21.81 |
| Pfizer Inc. PFE | 1 | $18.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.